David A Katz1,2, Julia C Dombrowski1,2, Michael Barry2, Dawn Spellman2, Teal R Bell3, Matthew R Golden1,4,2. 1. Department of Medicine, University of Washington, Seattle, WA. 2. HIV/STD Program, Public Health-Seattle and King County, Seattle, WA. 3. Washington State Department of Health, Office of Infectious Disease, Olympia, WA. 4. Department of Epidemiology, University of Washington, Seattle, WA.
Abstract
BACKGROUND: Men who have sex with men (MSM) with bacterial sexually transmitted diseases (STDs) are at elevated risk of HIV. We evaluated the integration of pre-exposure prophylaxis (PrEP) referrals into STD partner services (PS) for MSM. SETTING: King County, Washington. METHODS: Disease Intervention Specialists (DIS) in King County attempt to provide PS to all MSM with early syphilis and, as resources allow, MSM with gonorrhea or chlamydia. Our health department defines MSM with any of the following as at high HIV risk: early syphilis, rectal gonorrhea, methamphetamine/poppers use, sex work, or an HIV-unsuppressed partner. DIS offer high-risk MSM referral to our STD Clinic for PrEP and other MSM referral to community providers. In 2017, we interviewed a random sample of MSM offered referrals in 2016 to assess PrEP initiation after PS. RESULTS: From August 2014 to August 2017, 7546 cases of bacterial STDs were reported among HIV-negative MSM. DIS provided PS to 3739 MSM, of whom 2055 (55%) were at high risk. DIS assessed PrEP use in 1840 (90%) of these men, 895 (49%) of whom reported already using PrEP. DIS offered referrals to 693 (73%) of 945 MSM not on PrEP; 372 (54%) accepted. Among 132 interviewed for the random sample, men who accepted referrals at initial interview were more likely to report using PrEP at follow-up (32/68 = 47%) than those who did not (12/64 = 19%) (P = 0.0006). An estimated 10.4% of all interviewed MSM initiated PrEP following PS-based referral. CONCLUSIONS: Integrating PrEP referrals into STD PS is an effective population-based strategy to link MSM at high HIV risk to PrEP.
BACKGROUND:Men who have sex with men (MSM) with bacterial sexually transmitted diseases (STDs) are at elevated risk of HIV. We evaluated the integration of pre-exposure prophylaxis (PrEP) referrals into STD partner services (PS) for MSM. SETTING: King County, Washington. METHODS: Disease Intervention Specialists (DIS) in King County attempt to provide PS to all MSM with early syphilis and, as resources allow, MSM with gonorrhea or chlamydia. Our health department defines MSM with any of the following as at high HIV risk: early syphilis, rectal gonorrhea, methamphetamine/poppers use, sex work, or an HIV-unsuppressed partner. DIS offer high-risk MSM referral to our STD Clinic for PrEP and other MSM referral to community providers. In 2017, we interviewed a random sample of MSM offered referrals in 2016 to assess PrEP initiation after PS. RESULTS: From August 2014 to August 2017, 7546 cases of bacterial STDs were reported among HIV-negative MSM. DIS provided PS to 3739 MSM, of whom 2055 (55%) were at high risk. DIS assessed PrEP use in 1840 (90%) of these men, 895 (49%) of whom reported already using PrEP. DIS offered referrals to 693 (73%) of 945 MSM not on PrEP; 372 (54%) accepted. Among 132 interviewed for the random sample, men who accepted referrals at initial interview were more likely to report using PrEP at follow-up (32/68 = 47%) than those who did not (12/64 = 19%) (P = 0.0006). An estimated 10.4% of all interviewed MSM initiated PrEP following PS-based referral. CONCLUSIONS: Integrating PrEP referrals into STD PS is an effective population-based strategy to link MSM at high HIV risk to PrEP.
Authors: Julia E Hood; Susan E Buskin; Julia C Dombrowski; David A Kern; Elizabeth A Barash; David A Katz; Matthew R Golden Journal: AIDS Date: 2016-01-28 Impact factor: 4.177
Authors: Jeremy A Grey; Kyle T Bernstein; Patrick S Sullivan; Sarah E Kidd; Thomas L Gift; Eric W Hall; Abigail Hankin-Wei; Hillard S Weinstock; Eli S Rosenberg Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: Matthew R Golden; Matthew Hogben; H Hunter Handsfield; Janet S St Lawrence; John J Potterat; King K Holmes Journal: Sex Transm Dis Date: 2003-06 Impact factor: 2.830
Authors: Michael S Saag; Constance A Benson; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Michael J Mugavero; Paul E Sax; Davey M Smith; Melanie A Thompson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding Journal: JAMA Date: 2018-07-24 Impact factor: 56.272
Authors: Rachel A Silverman; David A Katz; Carol Levin; Teal R Bell; Dawn Spellman; Lisa St John; Evelyn Manley Rodriguez; Matthew R Golden; Ruanne V Barnabas Journal: Sex Transm Dis Date: 2019-08 Impact factor: 2.830
Authors: Keshet Ronen; Matthew R Golden; Julia C Dombrowski; Roxanne P Kerani; Teal R Bell; David A Katz Journal: Sex Transm Dis Date: 2019-10 Impact factor: 2.830
Authors: Peder Digre; Tigran Avoundjian; Kendra Johnson; David Peyton; Christie Lewis; Ruanne V Barnabas; Matthew R Golden; Christine M Khosropour Journal: Sex Transm Dis Date: 2021-03-01 Impact factor: 2.830
Authors: Ann M Dennis; Andrew Cressman; Dana Pasquale; Simon D W Frost; Elizabeth Kelly; Jalila Guy; Victoria Mobley; Erika Samoff; Christopher B Hurt; Candice Mcneil; Lisa Hightow-Weidman; Monique Carry; Matthew Hogben; Arlene C Seña Journal: Clin Infect Dis Date: 2022-02-11 Impact factor: 9.079
Authors: Rachael M Billock; Erika Samoff; Jennifer L Lund; Brian W Pence; Kimberly A Powers Journal: J Acquir Immune Defic Syndr Date: 2021-10-01 Impact factor: 3.771
Authors: M Bryant Howren; Shelby L Francis; Linnea A Polgreen; Cody Shafer; Angela Hoth; Michael E Ohl Journal: Public Health Rep Date: 2020-10-27 Impact factor: 2.792